Skip to main content
SpringerLink
Log in
Book cover

Health and Gender pp 177–184Cite as

Endocrine Disorders

  • Chapter
  • First Online:

  • 642 Accesses

Abstract

The different balance in the sex hormones, androgens and estrogens, is a cardinal aspect of the biology of gender difference and plays a fundamental role in maintaining the physiological state at each age of life [1]. However, the imbalance in sex hormones is involved in some metabolic diseases, with androgens playing an interesting sexually dimorphic role. The sexual dimorphism of androgens in the pathophysiology of metabolic disorders leads to inequalities in both preventive strategies and treatment between women and men.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Federman DD. The biology of human sex differences. N Engl J Med. 2006;354:1507–14.

    Article  CAS  Google Scholar 

  2. O’Reilly MW, House PJ, Tomlinson JW. Understanding androgen action in adipose tissue. J Steroid Biochem Mol Biol. 2014;143:277–84.

    Article  Google Scholar 

  3. Kloting N, Bluher M. Adipocyte dysfunction, inflammation and metabolic syndrome. Rev Endocr Metab Disord. 2014;15:277–87.

    Article  Google Scholar 

  4. Corbould A. Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women. J Endocrinol. 2007;192:585–94.

    Article  CAS  Google Scholar 

  5. Hernandez-Morante JJ, Perez-de-Heredia F, Lujan JA, Zamora S, Garaulet M. Role of DHEA-S on body fat distribution: gender- and depot-specific stimulation of adipose tissue lipolysis. Steroids. 2008;73:209–15.

    Article  CAS  Google Scholar 

  6. Corton M, Botella-Carretero JI, Benguria A, Villuendas G, Zaballos A, San Millan JL, Escobar-Morreale HF, Peral B. Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2007;92:328–37.

    Article  CAS  Google Scholar 

  7. Corton M, Botella-Carretero JI, Lopez JA, Camafeita E, San Millan JL, Escobar-Morreale HF, Peral B. Proteomic analysis of human omental adipose tissue in the polycystic ovary syndrome using two-dimensional difference gel electrophoresis and mass spectrometry. Hum Reprod. 2008;23:651–61.

    Article  CAS  Google Scholar 

  8. Schiffer L, Kempegowda P, Arlt W, O’Reilly MW. The sexually dimorphic role of androgens in human metabolic disease. Eur J Endocrinol. 2017;177:R125–43.

    Article  CAS  Google Scholar 

  9. Rincon J, Holmäng A, Wahlström EO, Lönnroth P, Björntorp P, Zierath JR, Wallberg-Henriksson H. Mechanisms behind insulin resistance in rat skeletal muscle after oophorectomy and additional testosterone treatment. Diabetes. 1996;45:615–21.

    Article  CAS  Google Scholar 

  10. Mauvais-Jarvis F, Clegg DJ, Hevener AL. The role of estrogens in control of energy balance and glucose homeostasis. Endocr Rev. 2013;34:309–38.

    Article  CAS  Google Scholar 

  11. Conway G, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Franks S, Gambineri A, Kelestimur F, Macut D, Micic D, Pasquali R, et al. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur J Endocrinol. 2014;171:P1–P29.

    Article  CAS  Google Scholar 

  12. Tosi F, Bonora E, Moghetti P. Insulin resistance in a large cohort of women with polycystic ovary syndrome: a comparison between euglycaemic-hyperinsulinaemic clamp and surrogate indexes. Hum Reprod. 2017;32:2515–21.

    Article  CAS  Google Scholar 

  13. Gambineri A, Repaci A, Patton L, Grassi I, Pocognoli P, Cognigni GE, Pasqui F, Pagotto U, Pasquali R. Prominent role of low HDL-cholesterol in explaining the high prevalence of the metabolic syndrome in polycystic ovary syndrome. Nutr Metab Cardiovasc Dis. 2009;19:797–804.

    Article  CAS  Google Scholar 

  14. Wang ET, Calderon-Margalit R, Cedars MI, Daviglus ML, Merkin SS, Schreiner PJ, Sternfeld B, Wellons M, Schwartz SM, Lewis CE, Williams OD, Siscovick DS, Bibbins-Domingo K. Polycystic ovary syndrome and risk for long-term diabetes and dyslipidemia. Obstet Gynecol. 2011;117:6–13.

    Article  Google Scholar 

  15. Gambineri A, Patton L, Altieri P, Pagotto U, Pizzi C, Manzoli L, Pasquali R. Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study. Diabetes. 2012;61:2369–74.

    Article  CAS  Google Scholar 

  16. Morgan CL, Jenkins-Jones S, Currie CJ, Rees DA. Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study. J Clin Endocrinol Metab. 2012;97:3251–60.

    Article  CAS  Google Scholar 

  17. Palmert MR, Gordon CM, Kartashov AI, Legro RS, Emans SJ, Dunaif A. Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87:1017–23.

    Article  CAS  Google Scholar 

  18. Gambineri A, Patton L, Vaccina A, Cacciari M, Morselli-Labate AM, Cavazza C, Pagotto U, Pasquali R. Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study. J Clin Endocrinol Metab. 2006;91:3970–80.

    Article  CAS  Google Scholar 

  19. Muka T, Nano J, Jaspers L, Meun C, Bramer WM, Hofman A, Dehghan A, Kavousi M, Laven JS, Franco OH. Associations of steroid sex hormones and sex hormone-binding globulin with the risk of Type 2 diabetes in women: a population-based cohort study and meta-analysis. Diabetes. 2017;66:577–86.

    Article  CAS  Google Scholar 

  20. Smith IE, Dowsett M. Aromatase inhibitors in breast cancer. N Engl J Med. 2003;348:2431–42.

    Article  CAS  Google Scholar 

  21. Ibarra-Gasparini D, Altieri P, Scarano E, Perri A, Morselli-Labate AM, Pagotto U, Mazzanti L, Pasquali R, Gambineri A. New insights on diabetes in Turner syndrome: results from an observational study in adulthood. Endocrine. 2018;59(3):651–60.

    Article  CAS  Google Scholar 

  22. Gupte AA, Pownall HJ, Hamilton DJ. Estrogen: an emerging regulator of insulin action and mitochondrial function. J Diabetes Res. 2015;2015:916585.

    Article  Google Scholar 

  23. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J, Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. J Am Med Assoc. 2002;288:321–33.

    Article  CAS  Google Scholar 

  24. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. J Am Med Assoc. 1998;280:605–13.

    Article  CAS  Google Scholar 

  25. de Villiers TJ, Hall JE, Pinkerton JV, Pérez SC, Rees M, Yang C, Pierroz DD. Revised global consensus statement on menopausal hormone therapy. Maturitas. 2016;91:153–5.

    Article  Google Scholar 

  26. Riecher-Rössler A. Sex and gender differences in mental disorders. Lancet Psychiatry. 2017;4:8–9.

    Article  Google Scholar 

  27. Riecher-Rössler A, Kulkarni J. Estrogens and gonadal function in schizophrenia and related psychoses. Curr Top Behav Neurosci. 2011;8:155–71.

    Article  Google Scholar 

Suggested Reading

  • Pasquali R. Obesity and androgens: facts and perspectives. Fertil Steril. 2006;85:1319–40.

    Article  CAS  Google Scholar 

  • Pasquali R, Gambineri A. Glucose intolerance states in women with the polycystic ovary syndrome. J Endocrinol Invest. 2013;36:648–53.

    Article  CAS  Google Scholar 

  • Pasquali R, Vicennati V, Gambineri A, Pagotto U. Sex-dependent role of glucocorticoids and androgens in the pathophysiology of human obesity. Int J Obes. 2008;32:1764–79.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Endocrinology Unit, Department of Medical and Surgical Science, S. Orsola-Malpighi Hospital, Alma Mater University of Bologna, Bologna, Italy

    Alessandra Gambineri, Paola Altieri & Daniela Ibarra-Gasparini

Authors
  1. Alessandra Gambineri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paola Altieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Daniela Ibarra-Gasparini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alessandra Gambineri .

Editor information

Editors and Affiliations

  1. Bologna Transcultural Psychosomatic Team (BoTPT), Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy

    Ilaria Tarricone

  2. Center for Gender Research and Early Detection, University of Basel Psychiatric Hospital, Basel, Switzerland

    Anita Riecher-Rössler

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Gambineri, A., Altieri, P., Ibarra-Gasparini, D. (2019). Endocrine Disorders. In: Tarricone, I., Riecher-Rössler, A. (eds) Health and Gender. Springer, Cham. https://doi.org/10.1007/978-3-030-15038-9_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-15038-9_20

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-15037-2

  • Online ISBN: 978-3-030-15038-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation